30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Richard Pops

Track

Insider profile

Currently holds positions in Alkermes Plc, Alkermes Plc, Neurocrine Biosciences Inc and Acceleron Pharma Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 10% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Alkermes Plc Sept. 16, 2011 -
Chairman of the Board, President, Chief Executive Officer Alkermes Plc Sept. 10, 2009 -
Independent Director Neurocrine Biosciences Inc April 16, 1998 -
Independent Director Acceleron Pharma Inc Jan. 1, 2004 -
Independent Director Epizyme Inc Sept. 1, 2008 - Oct. 31, 2020
Richard Pops's trades of Neurocrine Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-18 2026-05-15
PlS Planned sale
11,829 -46.2%
283.51
US$4,802,636 		11,829 -46.2% 283.51 US$4,802,636
2026-05-15 2026-05-15
PrS Proposed sale
13,511
159.90
US$4,943,927 		13,511 159.90 US$4,943,927
2026-05-15 2026-05-15
PrS Proposed sale
73,194
236.87
US$902,970 		73,194 236.87 US$902,970
2024-05-21 2024-05-17
PlS Planned sale
2,100 -6.2%
141.84
US$297,860 		2,100 -6.2% 141.84 US$297,860
2024-05-17 2024-05-17
PrS Proposed sale
2,100
141.91
US$298,011 		2,100 141.91 US$298,011
2024-03-15 2024-03-13
PlS Planned sale
23,200 -44.0%
140.33
US$3,255,621 		23,200 -44.0% 140.33 US$3,255,621
2024-03-12 2024-03-11
PlS Planned sale
100 -0.3%
140.00
US$14,000 		100 -0.3% 140.00 US$14,000
2024-03-12 2024-03-08
PlS Planned sale
1,700 -5.4%
140.05
US$238,078 		1,700 -5.4% 140.05 US$238,078
2024-03-08 2024-03-08
PrS Proposed sale
25,000
135.33
US$3,383,250 		25,000 135.33 US$3,383,250
2024-02-22 2024-02-20
PlS Planned sale
15,000 -33.7%
132.47
US$1,987,047 		15,000 -33.7% 132.47 US$1,987,047
2024-02-20 2024-02-20
PrS Proposed sale
15,000
132.31
US$1,984,650 		15,000 132.31 US$1,984,650
2023-01-05 2023-01-03
PlS Planned sale
15,000 -33.7%
119.20
US$1,788,045 		15,000 -33.7% 119.20 US$1,788,045
2022-05-11 2022-05-09
PlS Planned sale
7,500 -20.3%
76.30
US$572,252 		7,500 -20.3% 76.30 US$572,252
2022-05-11 2022-05-09
PlS Planned sale
7,500 -20.3%
76.29
US$572,211 		7,500 -20.3% 76.29 US$572,211
2022-05-06 2022-05-06
US Alkermes Plc (ALKS)
S Sale
93,747 -8.8%
27.85
US$2,611,313 		93,747 -8.8% 27.85 US$2,611,313
2022-05-06 2022-05-05
US Alkermes Plc (ALKS)
S Sale
32,288 -3.3%
28.59
US$923,227 		32,288 -3.3% 28.59 US$923,227
2022-05-06 2022-05-05
US Alkermes Plc (ALKS)
S Sale
221,222 -18.5%
27.95
US$6,183,243 		221,222 -18.5% 27.95 US$6,183,243
2021-05-19 2021-05-18
US Alkermes Plc (ALKS)
PlS Planned sale
150,000 -15.9%
21.90
US$3,285,405 		150,000 -15.9% 21.90 US$3,285,405
2021-05-12 2021-05-11
US Alkermes Plc (ALKS)
PlS Planned sale
60,297 -7.1%
22.30
US$1,344,798 		60,297 -7.1% 22.30 US$1,344,798
2021-05-12 2021-05-11
US Alkermes Plc (ALKS)
PlS Planned sale
89,703 -9.5%
21.95
US$1,968,541 		89,703 -9.5% 21.95 US$1,968,541
2020-05-14 2020-05-14
US Alkermes Plc (ALKS)
PlS Planned sale
75,000 -9.0%
15.00
US$1,125,232 		75,000 -9.0% 15.00 US$1,125,232
2020-05-07 2020-05-07
US Alkermes Plc (ALKS)
PlS Planned sale
50,000 -6.2%
14.63
US$731,265 		50,000 -6.2% 14.63 US$731,265
2020-04-03 2020-04-02
US Alkermes Plc (ALKS)
PlS Planned sale
50,000 -6.2%
13.79
US$689,500 		50,000 -6.2% 13.79 US$689,500
2020-03-26 2020-03-26
US Alkermes Plc (ALKS)
PlS Planned sale
75,000 -9.0%
14.36
US$1,077,225 		75,000 -9.0% 14.36 US$1,077,225
2020-03-19 2020-03-19
US Alkermes Plc (ALKS)
PlS Planned sale
15,986 -2.1%
15.04
US$240,393 		15,986 -2.1% 15.04 US$240,393
2020-03-19 2020-03-19
US Alkermes Plc (ALKS)
PlS Planned sale
48,668 -5.9%
14.51
US$706,168 		48,668 -5.9% 14.51 US$706,168
2020-03-19 2020-03-19
US Alkermes Plc (ALKS)
PlS Planned sale
10,346 -1.2%
13.42
US$138,867 		10,346 -1.2% 13.42 US$138,867
2019-09-23 2019-09-19
US Alkermes Plc (ALKS)
PlS Planned sale
100,000 -12.2%
21.54
US$2,153,550 		100,000 -12.2% 21.54 US$2,153,550
2019-09-13 2019-09-12
US Alkermes Plc (ALKS)
PlS Planned sale
100,000 -12.2%
22.68
US$2,268,220 		100,000 -12.2% 22.68 US$2,268,220
2019-09-06 2019-09-05
US Alkermes Plc (ALKS)
PlS Planned sale
100,000 -12.2%
20.18
US$2,017,830 		100,000 -12.2% 20.18 US$2,017,830
2019-05-24 2019-05-23
US Alkermes Plc (ALKS)
PlS Planned sale
50,000 -6.5%
24.22
US$1,211,150 		50,000 -6.5% 24.22 US$1,211,150
2019-05-24 2019-05-16
US Alkermes Plc (ALKS)
PlS Planned sale
60,000 -7.7%
25.42
US$1,525,278 		60,000 -7.7% 25.42 US$1,525,278
2019-03-14 2019-03-13
US Alkermes Plc (ALKS)
PlS Planned sale
15,829 -2.2%
33.51
US$530,485 		15,829 -2.2% 33.51 US$530,485
2019-03-14 2019-03-12
US Alkermes Plc (ALKS)
PlS Planned sale
44,171 -5.8%
33.24
US$1,468,447 		44,171 -5.8% 33.24 US$1,468,447
2019-03-07 2019-03-05
US Alkermes Plc (ALKS)
PlS Planned sale
50,000 -6.5%
33.63
US$1,681,740 		50,000 -6.5% 33.63 US$1,681,740
2016-05-26 2016-05-25
PlS Planned sale
15,000 -49.2%
46.72
US$700,800 		15,000 -49.2% 46.72 US$700,800
2016-03-23 2016-03-22
US Alkermes Plc (ALKS)
PlS Planned sale
15,000 -2.5%
32.05
US$480,717 		15,000 -2.5% 32.05 US$480,717
2016-03-23 2016-03-22
US Alkermes Plc (ALKS)
PlS Planned sale
10,000 -1.7%
31.36
US$313,636 		10,000 -1.7% 31.36 US$313,636
2016-03-16 2016-03-15
US Alkermes Plc (ALKS)
PlS Planned sale
25,000 -4.2%
31.40
US$784,910 		25,000 -4.2% 31.40 US$784,910
2004-07-02 2004-07-01
US Alkermes Plc (ALKS)
PlS Planned sale
24,294 -8.0%
13.41
US$325,821 		24,294 -8.0% 13.41 US$325,821